Johnson & Johnson single-shot COVID-19 vaccine phase III data published in New England Journal of Medicine
Johnson & Johnson announced publication in the New England Journal of Medicine of primary data from the Phase III ENSEMBLE clinical trial for its single-dose COVID-19 vaccine, developed… read more.